English  |  正體中文  |  简体中文  |  Items with full text/Total items : 6024/14565 (41%)
Visitors : 13716062      Online Users : 287
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: https://ir.fy.edu.tw:8080/ir/handle/987654321/17774


    Title: Development of Doxorubicin Quantification by Reductive Amination
    Authors: Lin, Yi-Reng;Wu, Chia-En;Huang, Mei-Fang;Liang, Shih-Shin
    Contributors: 輔英科技大學 生物科技系
    Date: 2017-04-01
    Issue Date: 2017-09-13 14:11:00 (UTC+8)
    Abstract: Background: Doxorubicin (Dox) is a medicine for cancer chemotherapy in various cancers, such as leukaemia, lympyoma and breast cancer. However, the Dox metabolite induced cardiotoxicity. Therefore, how to monitor exactly the concentration of Dox and its metabolites in plasma or serum is an important issue. Methods: Doxorubicin was dissolved in ethanol to prepare 10000 μg/mL solutions. Doxorubicin solution (20 μL) was transferred into two tubes and each tube was adjusted the pH value to 5.6 using sodium acetate buffer (160 μL). The samples were allowed to react with 10 μL 4% formaldehyde-H2 and 10 μL 4% formaldehyde-D2 solutions for 5 min, respectively. Eventually, the modified samples were reduced for 1 h in the presence of 0.6 M NaBH3CN (10 μL). Individual samples were injected into the mass spectrometer by syringe to determine m/z values and establish MRM transition. The signal enhancement, illustration of calibration curve, and method validation were according to the MS detection of MRM transitions between modified and unmodified compounds. Results: The signal of modified Dox was enhanced by reductive amination, and the signal enhancement was improved 190.8 % which was compared with unmodified Dox. The linearity of doxorubicin was illustrated from the range of 5.0-1000.0 ng/mL, and the limit of detection and the limit of quantitation were 1.37 and 1.46 ng/mL, respectively. The method validation was spiking doxorubicin with low, intermediate, and high concentrations including 20 ng/mL, 100 ng/mL, and 500 ng/mL in human serum, and recoveries were between 80% to 98%. Conclusion: Via reductive amination of formaldehyde, a novel, laborless, inexpensive and convenient method was developed for the absolute quantification of doxorubicin. Furthermore, doxorubicin would be reduced to generate doxorubicinol which is a metabolite of doxorubicin. Therefore, this method could be utilized to quantitate doxorubicin as well as doxorubicinol. The quantification of doxorubicin and its metabolite, doxorubicinol, could share the same internal standard and standard for calibration curve illustration. Besides, the novel modification of reductive amination enhanced MS signal intensities, facilitating the absolute quantification of doxorubicin.
    Relation: Current Analytical Chemistry, Volume 13, Issue 4,Pages 270-276
    Appears in Collections:[生物科技系] 期刊論文

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML437View/Open


    All items in FYIR are protected by copyright, with all rights reserved.


    本網站典藏內容為學術研究目的之提供,請尊重著作權人之權益合理使用,請勿任意重製、轉貼、改作及散佈。

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback